UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2025	Dec. 31, 2024	[1]
CURRENT ASSETS
Cash and cash equivalents	$ 286,558,598	$ 233,318,766
Short-term investments	20,549,084	22,304,829
Accounts receivable, net	330,625,348	295,344,353
Inventories, net	408,934,806	436,497,445
Prepaid expenses and other	42,002,767	49,862,777
Total current assets	1,088,670,603	1,037,328,170
PLANT AND EQUIPMENT—NET	734,551,557	728,481,467
OTHER ASSETS
Goodwill	340,668,927	340,668,927
Long-term investments	300,626,514	339,604,044
Intangible assets, net	190,832,346	195,157,160
Deferred tax asset	53,623,835	53,154,832
Patents and other assets, net	73,575,446	66,426,375
Total other assets	959,327,068	995,011,338
TOTAL ASSETS	2,782,549,228	2,760,820,975
CURRENT LIABILITIES
Accounts payable	162,899,037	168,314,912
Accrued liabilities	103,734,311	84,377,764
Total current liabilities	266,633,348	252,692,676
OTHER NON-CURRENT LIABILITIES	36,498,377	36,028,644
TOTAL LIABILITIES	303,131,725	288,721,320
SHAREHOLDERS’ INVESTMENT
Common stock	13,489,027	13,632,448
Additional paid-in capital	1,011,756,899	1,010,440,420
Retained earnings	1,454,610,199	1,450,287,128
Accumulated other comprehensive loss	(5,030,122)	(6,409,341)
TOTAL GENTEX CORPORATION SHAREHOLDERS' INVESTMENT	2,474,826,003	2,467,950,655
Non-controlling Interest	4,591,500	4,149,000
TOTAL LIABILITIES AND SHAREHOLDERS' INVESTMENT	$ 2,782,549,228	$ 2,760,820,975

[1] The condensed consolidated balance sheet at December 31, 2024 has been derived from the audited consolidated financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.